SALT LAKE CITY, Sept. 03, 2024 (GLOBE NEWSWIRE) — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced top–line results of the SYCAMORE trial, a [...] Read more »
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
FDA regulatory submission for the Company’s Genio® device [...] Read more »
Nyxoah Sonne la Cloche de Clôture sur le Nasdaq alors qu'elle se Prépare à Lancer sa Technologie Innovante pour l'Apnée du Sommeil sur le Marché Américain
Nyxoah Sonne la Cloche de Clôture sur le Nasdaq alors qu'elle se Prépare à Lancer sa Technologie Innovante pour l'Apnée du Sommeil sur le Marché Américain
[...] Read more »Blue Hat Announced Execution of $66.49 Million Gold Acquisition
HONG KONG, Aug. 29, 2024 (GLOBE NEWSWIRE) — Blue Hat Interactive Entertainment Technology ("BHAT" or the "Company") (NASDAQ: BHAT) announced the execution of a 1,000–kilogram (approximately 2,204.62 pounds) gold [...] Read more »
Volt Mobility Enters into $210 Million Contract with Mullen Automotive to Purchase 3,000 Class 1 and Class 3 EV Cargo Vans and Trucks
Mullen to receive initial $3 million deposit and will begin shipping first vehicles immediately
Volt, a leading UAE–based commercial leasing company with [...] Read more »
Zoom Appoints Mike Fenger to Board of Directors
SAN JOSE, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM) announced that it has appointed Mike Fenger, vice president Worldwide Sales, Apple, as an independent director on Zoom’s Board of [...] Read more »
DigiAsia Corp. Appoints Andreas Gregori to its AI Strategic Advisory Board
~ The Addition Strengthens the Delivery of Meaningful AI Fintech Solutions for its Enterprise Clients ~
NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) — DigiAsia Corp. (NASDAQ: [...] Read more »
Entera Bio to Participate in Upcoming Investor and Scientific Conferences
JERUSALEM, Aug. 20, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, [...] Read more »
Montana Technologies Announces Memorandum of Understanding with TenX Investment to Deploy AirJoule® for Water Security and Sustainability in the United Arab Emirates
RONAN, Mont., Aug. 15, 2024 (GLOBE NEWSWIRE) — Montana Technologies Corporation (NASDAQ: AIRJ) (“Montana Technologies” or the “Company”), the developer of the transformational [...] Read more »
Blue Hat Expands into Gold Trading with Strategic Partnerships As Gold Prices Rise Amid Economic Optimism
HONG KONG, Aug. 15, 2024 (GLOBE NEWSWIRE) — Blue Hat Interactive Entertainment Technology (NASDAQ:BHAT) is emerging as a key player in gold trading industry. As reported by Reuters, since August 1st, 2024, gold prices [...] Read more »
Cellebrite Announces Redemption of All Outstanding Warrants
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 15, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT) (“Cellebrite,” the “Company” or [...] Read more »
Cellebrite Appoints Tech Veteran Troy K. Richardson to Board of Directors
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier digital investigative solutions for the public and private sectors, announced today [...] Read more »
Entera Bio Reports Q2 2024 Financial Results and Provides Business Updates
JERUSALEM , Aug. 09, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, [...] Read more »
Recursion and Exscientia Enter Definitive Agreement to Create a Global Technology-Enabled Drug Discovery Leader with End-to-End Capabilities
- Brings together Recursion’s scaled biology exploration and translational capabilities with Exscientia’s precision chemistry design and small molecule automated synthesis capabilities to create a leading [...] Read more »
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
REGULATED INFORMATION
Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating Results
FDA regulatory submission complete, U.S. approval on track for end of [...] Read more »